{"id":225576,"date":"2026-02-26T13:35:29","date_gmt":"2026-02-26T10:35:29","guid":{"rendered":"https:\/\/new-inbit.dev-praxis.gr\/?post_type=hta_library&#038;p=225576"},"modified":"2026-02-26T13:35:32","modified_gmt":"2026-02-26T10:35:32","slug":"transcatheter-aortic-valve-implantation-tavi-a-health-technology-assessment-update","status":"publish","type":"hta_library","link":"https:\/\/www.inbit.gr\/el\/hta_library\/transcatheter-aortic-valve-implantation-tavi-a-health-technology-assessment-update\/","title":{"rendered":"Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update"},"content":{"rendered":"\n<p>Transcatheter Aortic Valve Insertion \u2013 TAVI \u2013 is a technique involving the implantation\u00a0of an artificial valve into a narrowed aortic valve without the need to stop the heart.\u00a0There are two variants of this procedure. In the first, the artificial valve is inserted\u00a0through an artery, generally the femoral artery, in which case it is called a &#8220;transfemoral\u00a0TAVI&#8221;. If, however, due to significant atheromatosis, neither of the two femoral arteries\u00a0is accessible, a TAVI can also be performed directly through the thoracic wall and the\u00a0apex of the heart. This variant is called a &#8220;transapical TAVI&#8221;.\u00a0Since 2007, two different TAVI valves have been launched on the market in Europe: the\u00a0Sapien\u00ae valve of Edwards Lifesciences and the CoreValve\u00ae of Medtronic. Thousands of\u00a0each type have already been implanted.\u00a0In 2008, the KCE published its first report on this technique. The conclusion was that\u00a0reimbursement of TAVI could not be supported at that time due to safety issues for\u00a0patients and because the target population was not sufficiently defined. The proposal\u00a0was made to review this recommendation at the time of publication of the results of the\u00a0PARTNER (Placement of AoRtic TraNscathetER valve) trial, a randomised clinical trial\u00a0with the Sapien\u00ae valve that was ongoing at that time. The results were published in\u00a0September 2010 and June 2011 and additional analyses of those same results were\u00a0released in the minutes of a meeting of the US Food and Drug Administration (FDA) on\u00a020 July 2011. We also contacted the trial sponsor and received additional data.<\/p>\n","protected":false},"featured_media":0,"template":"","categories":[19],"tags":[107,111],"class_list":["post-225576","hta_library","type-hta_library","status-publish","hentry","category-other","tag-tavi","tag-transcatheter"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/hta_library\/225576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/hta_library"}],"about":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/types\/hta_library"}],"wp:attachment":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/media?parent=225576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/categories?post=225576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/tags?post=225576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}